BREAKING: Pfizer Makes Shock Announcement About Child Vax – Parents Stunned

Pfizer-BioNTech has announced that they will not be applying with the Food and Drug Administration to have its Covid-19 vaccine approved for use by children aged six months to four years.

The decision caught many off guard as the large pharmaceutical companies producing coronavirus vaccines have aggressively sought to get their products approved for use by young children.

According to an announcement on Friday, Pfizer is waiting on data to be collected on a new three-dose version of the Covid-19 vaccine. The data should be available in early April, which sets a prospective timetable for the approval process.

What is particularly interesting is Pfizer’s decision to wait on continuing through the FDA’s approval process comes as many outside experts have warned of faulty data around vaccines for young children.

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, sought to reassure Americans saying that the FDA takes “responsibility for reviewing these vaccines very seriously because we’re parents as well.”

Regardless of what happens in the next few weeks, it seems inevitable that the Covid-19 vaccine will be authorized for general use by young children in the coming months.

Read the full story here.

Share on facebook
Share to Facebook

Leave a Reply

Your email address will not be published.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.